引用本文: | Ho?owiecki J,Grosicki S,Kyrcz-Krzemien S,Skotnicki AB,Piatkowska-Jakubas B,Warzocha K,Seferynska I,Zdziarska B.Daunorubicin,cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety,tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study[J].Annals of Hematology,2008,87(5):361-367. |